Johnson & Johnson 4Q Revenues: $18.4 billion (+5%) 4Q Earnings: $3.5 billion (+37%) FY Revenues: $71.3 billion (+6%) FY Earnings: $13.8 billion (+27%) Comments: Pharmaceutical sales were $7.3 billion in the quarter, up 12%, and $28.1 billion for the year, up 11%. Domestic sales increased 7% in the quarter and 12% for the year. International sales increased 2% in the quarter and 10% for the year. Sales growth was driven by REMICADE and SIMPONI, STELARA, INVEGA SUSTENNA/XEPLION, PREZISTA,...